Sutent: observational study

OTHER2 trials

Sponsors

Pfizer

Conditions

Metastatic Renal Cell CarcinomaRenal Cell Carcinoma

Unknown Phase

SUTENT® In The First Line Treatment Of Renal Cell Carcinoma

CompletedNCT00460798

PfizerRenal Cell Carcinoma

Start: 2007-02-28End: 2009-09-30Updated: 2010-11-16

A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival

CompletedNCT01917214

PfizerMetastatic Renal Cell Carcinoma

Start: 2013-08-31End: 2014-03-31Updated: 2015-03-26